lysophosphatidic acid has been researched along with Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Anthony, DD; Chance, MR; Compan, A; Falck-Ytter, Y; Hirsch, A; Judge, C; Kostadinova, L; Li, X; Popkin, DL; Rife, K; Rodriguez, B; Schlatzer, DM; Shive, CL; Zebrowski, E | 1 |
| Jianmin, W; Maluccio, MA; Skill, NJ; Tector, AJ; Yan, X; Zhao, Z | 1 |
2 other study(ies) available for lysophosphatidic acid and Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted
| Article | Year |
|---|---|
During Hepatitis C Virus (HCV) Infection and HCV-HIV Coinfection, an Elevated Plasma Level of Autotaxin Is Associated With Lysophosphatidic Acid and Markers of Immune Activation That Normalize During Interferon-Free HCV Therapy.
Topics: Adult; Aged; Anti-HIV Agents; Antigens, CD; Antigens, Differentiation, Myelomonocytic; Biomarkers; Coinfection; Female; Hepacivirus; Hepatitis C; HIV; HIV Infections; Humans; Interferons; Interleukin-6; Lipopolysaccharide Receptors; Lysophospholipids; Male; Middle Aged; Monocytes; Phosphoric Diester Hydrolases; Plasma; Receptors, Cell Surface | 2016 |
Lysophospholipid variants in hepatocellular carcinoma.
Topics: Carcinoma, Hepatocellular; Fatty Liver; Hepatitis C; Humans; Liver Neoplasms; Liver Transplantation; Lysophospholipids; Mass Spectrometry; Non-alcoholic Fatty Liver Disease; Receptors, Lysophosphatidic Acid; RNA, Messenger; Tumor Necrosis Factor-alpha | 2013 |